title: Evaluating the "A" component of the SAFE strategy.
authors.forename: Deborah
authors.initials: D
authors.lastname: Dean
authors.forename: Berna
authors.initials: B
authors.lastname: Atik
authors.forename: T K Thanh
authors.initials: TK
authors.lastname: Ton
authors.forename: Q Luong
authors.initials: QL
authors.lastname: Vu
authors.forename: Stephen
authors.initials: S
authors.lastname: Lagree
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D017963:Azithromycin / Q000627:therapeutic use*; D003140:Communicable Disease Control / Q000379:methods*; D006266:Health Education; D006801:Humans; D008137:Longitudinal Studies; D012959:Socioeconomic Factors; D014141:Trachoma / Q000188:drug therapy* / Q000453:epidemiology / Q000276:immunology; D014744:Vietnam
chemical_list: D000900:Anti-Bacterial Agents; D017963:Azithromycin